Neurocrine Biosciences Inc Dividends
The next dividend date for Neurocrine Biosciences Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Neurocrine Biosciences Inc (NBIX)
More About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Owning Neurocrine Biosciences Inc Stock on the Dividend Date
If you own Neurocrine Biosciences Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Neurocrine Biosciences Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Neurocrine Biosciences Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Neurocrine Biosciences Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Neurocrine Biosciences Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Neurocrine Biosciences Inc Dividends
You can contact us any time if you would like to ask questions about Neurocrine Biosciences Inc dividends or anything else related to the stock market.